Episode 10 - Emerging Evidence in Myasthenia Gravis: A Special Edition Podcast Series - Part 2 Innovations in MG Therapeutics

Join Dr. Nicholas Silvestri in this 10-minute, special edition podcast series on myasthenia gravis (MG). Today’s podcast titled, Innovations in MG Therapeutics, focuses on the latest therapies, including complement inhibitors and FcRn antagonists, and their application in personalized treatment plans.Launch Date: April 21, 2025Release Date: April 21, 2025Expiration Date: March 31, 2026FACULTYNicholas Silvestri, MD, FAANProfessor of Neurology, Associate Dean for Student and Academic AffairsDepartment of NeurologyJacobs School of Medicine & Biomedical SciencesThis podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.